EMA Explains Steps Firms Should Take To Reduce Risk Of medication errors
This article was originally published in SRA
Executive Summary
The effects of the EU pharmacovigilance legislation reach far and wide, and some aspects of the safety monitoring system are still being implemented. The latest development - and one that means companies will have to pay more attention to aspects such as labeling and product design - is a new set of guidance documents from the European Medicines Agency on preventing, coding, recording and analyzing medication errors1.